Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 2021 Apr 16;89(5):e00040-21. doi: 10.1128/IAI.00040-21

In Vivo and In Vitro Impairments in T Helper Cell and Neutrophil Responses against Mucor irregularis in Card9 Knockout Mice

Lingyue Sun a,b,c,d,*,#, Shuzhen Zhang a,b,c,d,*,#, Zhe Wan a,b,c,d, Ruoyu Li a,b,c,d,, Jin Yu a,b,c,d,
Editor: Mairi C Noverre
PMCID: PMC8091082  PMID: 33649049

Mucor irregularis is a frequently found fungus in Asia, especially China, and it causes primary cutaneous mucormycosis with a high rate of disfigurement. Caspase recruitment domain-containing protein 9 (Card9) is an essential adaptor molecule downstream of C-type lectin receptors. It mediates the activation of nuclear factor kappa B (NF-κB), regulates T helper 1 (Th1) and Th17 differentiation, and plays an important role in fungal immune surveillance. CARD9 deficiency correlates with the increased susceptibility to many fungal infections, including cutaneous mucormycosis caused by M. irregularis.

KEYWORDS: Mucor irregularis, Card9 knockout, T helper cell, neutrophil

ABSTRACT

Mucor irregularis is a frequently found fungus in Asia, especially China, and it causes primary cutaneous mucormycosis with a high rate of disfigurement. Caspase recruitment domain-containing protein 9 (Card9) is an essential adaptor molecule downstream of C-type lectin receptors. It mediates the activation of nuclear factor kappa B (NF-κB), regulates T helper 1 (Th1) and Th17 differentiation, and plays an important role in fungal immune surveillance. CARD9 deficiency correlates with the increased susceptibility to many fungal infections, including cutaneous mucormycosis caused by M. irregularis. However, the underlying immunological mechanisms were not elucidated. Our study established a murine model of subcutaneous M. irregularis infection, and we isolated immune cells, including bone marrow-derived macrophages, bone marrow-derived dendritic cells, naive T cells, and neutrophils, from wild-type (WT) and Card9 knockout (Card9−/−) mice to examine the antifungal effect of Card9 on M. irregularis in vivo and in vitro. Card9−/− mice exhibited increased susceptibility to M. irregularis infection. Impaired local cytokine and chemokine production, NF-κB (p65) activation, and Th1/17 cell differentiation and partially impaired neutrophil-dependent antifungal immunity were observed in Card9−/− mice. This work enriches our knowledge of the relationship between CARD9 deficiency and mucormycosis.

INTRODUCTION

Mucormycosis is characterized by a rapidly progressing angioinvasion with ensuing thrombosis and tissue necrosis, and it is a potentially lethal fungal disease caused by species in the Mucorales (1). Mucormycosis is the third most prevalent invasive fungal disease in immunosuppressed individuals, after candidiasis and aspergillosis. Some cases appear in immunocompetent populations (2). The risk factors of mucormycosis include the use of corticosteroids, neutropenia, trauma, diabetes mellitus, organ transplantations, and chemotherapy (3). There are different clinical forms of infection, including rhinocerebral, cutaneous, pulmonary, gastrointestinal, and disseminated (4). Mucor irregularis (previously Rhizomucor variabilis) is a frequently found fungus in Asia, especially in China, and it generally leads to primary cutaneous mucormycosis in immunocompetent individuals following the disruption of cutaneous barriers (57). However, we recently identified the first case of cutaneous mucormycosis caused by M. irregularis in a patient with caspase recruitment domain-containing protein 9 (CARD9) deficiency (8, 9).

Card9 is primarily expressed in myeloid cells, and it is an essential adaptor molecule downstream of C-type lectin receptors (CLRs) that mediates the activation of nuclear factor kappa B (NF-κB), regulates T helper 1 (Th1) and Th17 differentiation, and plays an important role in fungal immune surveillance. CARD9 links innate immunity to adaptive immunity, and CARD9 deficiency is attributed to much more severe immune disorders than the deficiency of a single CLR (10). Human CARD9 genetic mutations are relevant to severe fungal infections: e.g., infections caused by dematiaceous fungal infections (1113), mucocutaneous or invasive candidiasis (1416), extrapulmonary Aspergillus infection (17), or deep dermatophytosis (1820). A previous study reported that a patient with CARD9 mutations and deep dermatophytosis caused by Microsporum ferrugineum exhibited decreased proinflammatory cytokine production and Th cell differentiation (18). Other patients with CARD9 deficiency and phaeohyphomycosis exhibited impaired cytokine and chemokine production and NF-κB activation and decreased Th responses (12). All of the pathogenic fungi identified in CARD9 deficiency patients were from the phylum Ascomycota (21), and M. irregularis is the first fungus belonging to the order Mucorales. Mucorales spores lack a rodlet immunoprotective hydrophobin layer and induce different responses in human mononuclear cells compared to Ascomycota spores (22).

To investigate the relationship between CARD9 deficiency and M. irregularis infection and the underlying immune mechanisms, we established an M. irregularis infection murine model and isolated immune cells from wild-type (WT) and Card9 knockout (Card9−/−) mice to examine the antifungal effects of Card9 on M. irregularis in vivo and in vitro.

RESULTS

Card9−/− mice exhibited increased susceptibility to M. irregularis infection.

We injected M. irregularis inocula into the hind footpads of WT and Card9−/− mice to establish a mucormycosis murine model that mimics the clinical onset of cutaneous mucormycosis and investigate the antifungal role of Card9 in M. irregularis infection.

Footpad swelling and lesions gradually healed in WT mice and were completely recovered at 8 weeks postinoculation (wpi). Neither necrosis nor ulceration emerged during the whole observation period (Fig. 1a). Fungal elements and the inflammatory response were absent in histopathological examination of the footpads at 4 wpi (Fig. 1b). Fungal burdens in the footpads and inguinal lymph nodes peaked at 3 days postinoculation (dpi) and were reduced to zero at 7 and 28 dpi (Fig. 1c).

FIG 1.

FIG 1

Card9−/− mice display increased susceptibility to M. irregularis infection. The hind footpads of WT and Card9−/− mice were subcutaneously injected with 2.5 × 108 M. irregularis spores. (a) Natural courses of infection in WT and Card9−/− mice (n = 6/group). Shown are representative images of different observation time points (0 wpi [normal], 4 wpi and 8 wpi). (b) Histopathology of H&E- and PAS-stained footpads from WT and Card9−/− mice harvested at 8 wpi (n = 3/group). (c) Fungal burdens of the footpads and inguinal lymph nodes of WT and Card9−/− mice at 3, 7, and 28 dpi (n = 3/group). ns, not significant; *, P < 0.05; **, P < 0.01; and ****, P < 0.0001.

However, persistent swelling was found throughout the infection course in Card9−/− mice. Fast-growing necrosis, ulcers, crustal lesions, and disfigurement were observed, which resembled the clinical manifestations of M. irregularis infection (Fig. 1a). Inflammatory cells, including lymphocytes, histocytes, and multinuclear giant cells, infiltrated into the footpads of Card9−/− mice (Fig. 1b). Abundant nonseptate, wide, irregularly branched hyphae were discovered on histopathological examination of the footpads at 4 wpi (Fig. 1b). Although the fungal burdens of the footpads and inguinal lymph nodes gradually decreased over time, these burdens always remained statistically higher than the corresponding sites in WT mice, which illustrates the defects in eliminating fungal infections in Card9−/− mice (Fig. 1c).

Impaired local cytokine and chemokine production in Card9−/− mice.

Because of the different phenotypes of WT and Card9−/− mice, we measured the levels of inflammatory cytokines and chemokines in footpad homogenates. Card9−/− mice exhibited sharp decreases in the levels of interleukin-6 (IL-6), IL-10, tumor necrosis factor alpha (TNF-α), the Th1-cytokine gamma interferon (IFN-γ), and the Th17 cytokine IL-17A at 3 dpi and a marked increase in the level of the Th2 cytokine IL-4. Card9−/− mice exhibited significant decreases in the levels of IL-6 and TNF-α at 7 dpi and increases in the levels of IL-4 and IL-10 compared to WT mice (Fig. 2).

FIG 2.

FIG 2

Impaired local cytokine production and Th cell responses in Card9−/− mice. IFN-γ, IL-17A, IL-6, TNF-α, IL-4, and IL-10 levels were assessed at 0, 3, and 7 dpi (n = 6/group). Data are shown as the mean ± standard deviation (SD) and were analyzed by unpaired t tests. ns, not significant; *, P < 0.05; **, P < 0.01; and ****, P < 0.0001.

Statistically significant reductions in the mRNA levels of the chemokines CXCL1 and CXCL2 and the cytokines TNF-α and IL-6 at 3 dpi were found in the footpads of Card9−/− mice (Fig. 3a). These results indicated that Card9 participated in the production of cytokines TNF-α and IL-6 and chemokines CXCL1 and CXCL2 in M. irregularis infections.

FIG 3.

FIG 3

Impaired local chemokine production in Card9−/− mice and impaired NF-κB (p65) activation in Card9−/− bone marrow-derived macrophages. (a) CXCL1, CXCL2, TNF-α, and IL-6 levels were assessed at 3 dpi (n = 4/group). Data are shown as the mean ± SD and were analyzed by unpaired t tests. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001. (b) NF-κB (p65) activation was impaired at 60 min in Card9−/− bone marrow-derived macrophages compared with WT bone marrow-derived macrophages.

Impaired NF-κB (p65) activation in Card9−/− bone marrow-derived macrophages.

To further clarify the signaling pathways participating in the immune response to M. irregularis, we detected NF-κB pathway activity in bone marrow-derived macrophages (BMDMs) from WT or Card9−/− mice stimulated with inactivated M. irregularis swollen spores.

NF-κB (p65) translocates into the cell nucleus when Card9 is activated via the Card9-dependent NF-κB pathway. We measured the specific NF-κB (p65) DNA binding activity in BMDMs and found a marked reduction in NF-κB (p65) activation in Card9−/− BMDMs (Fig. 3b). These results indicated the importance of Card9 in the NF-κB (p65) activation in M. irregularis infections.

Differences in cytokine secretion by dendritic cells and Th1/17 cell differentiation induced by resting or swollen spores of M. irregularis.

Innate immunity and adaptive immunity are essential in antifungal immunity. As the most important professional antigen-presenting cells (APCs), immature bone marrow-derived dendritic cells (BMDCs) process and present antigens to prime naive T cells. To identify the cytokines secreted by DCs that shaped Th1/Th17 cell differentiation, we cocultured immature DCs with paraformaldehyde-inactivated resting spores of M. irregularis for 24 h and examined the levels of IL-1β, IL-23, and IL-12p70 in the culture supernatant. We did not observe obvious IL-1β, IL-23, or IL-12p70 secretion (Fig. 4a). To clarify whether cytokines secreted by DCs against M. irregularis were stage specific, we prepared swollen spores of M. irregularis and found statistically significant increases in the secretion of IL-1β, IL-23, and IL-12p70 with the swollen spores compared to resting spores (Fig. 4a).

FIG 4.

FIG 4

Differences in cytokine secretion by BMDCs and Th1/17 cell differentiation induced by resting or swollen spores of M. irregularis. (a) Swollen spores of M. irregularis induced more secretion of IL-1β, IL-23, and IL-12p70 and differentiation of Th1/17 cells than resting spores. (b) Swollen spores of M. irregularis induced higher expression of T-bet and RORγt than did resting spores. (c) Swollen spores of M. irregularis induced higher secretion of IL-17A and IFN-γ than did resting spores. (d) Swollen spores of M. irregularis induced more Th1/17 cell differentiation than resting spores. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001.

We investigated whether the adaptive immune responses induced by different stages of spores were disparate and noticed that the transcriptional levels of T-bet and ROR-γt and the protein levels of secreted IFN-γ and IL-17A were also significantly higher in the swollen spore-stimulated group than the resting spore-stimulated group (Fig. 4b and c). Swollen spores also induced a statistically significant improvement in Th1/Th17 cell differentiation (Fig. 4d). All the results mentioned above indicated that resting or swollen spores of M. irregularis could induce different cytokine secretion by dendritic cells and Th1/17 cell differentiation.

Card9 is indispensable in cytokine secretion by DCs and Th1/17 cell differentiation induced by swollen spores of M. irregularis.

Based on the in vivo findings in Card9−/− mice, we further determined the in vitro antifungal effect of Card9 on cytokine secretion by DCs and Th1/17 cell differentiation induced by swollen spores of M. irregularis. We found that the secretion of IL-1β, IL-23, and IL-12p70 by DCs from Card9−/− mice stimulated by swollen spores was significantly lower than that by the DCs from WT mice (Fig. 5a). We further observed that the expression of T-bet and ROR-γt and the secretion of IL-17A and IFN-γ were also lower in Card9−/− mice than WT mice (Fig. 5b and c). The swollen spore-induced Th1/Th17 cell differentiation was lower in Card9−/− mice than WT mice (Fig. 5d). Our results indicated that Card9 is indispensable in cytokine secretion by DCs and Th1/17 cell differentiation induced by swollen spores of M. irregularis.

FIG 5.

FIG 5

Card9 is indispensable in cytokine secretion by dendritic cells and Th1/17 cell differentiation induced by swollen spores of M. irregularis. (a) The secretion of IL-1β, IL-23, and IL-12p70 by BMDCs from Card9−/− mice stimulated by swollen spores was significantly lower than that by BMDCs from WT mice. (b) The expression of T-bet and RORγt induced by swollen spores of M. irregularis was decreased in Card9−/− mice. (c) The secretion of IL-17A and IFN-γ induced by swollen spores of M. irregularis was reduced in Card9−/− mice. (d) Th1/Th17 cell differentiation induced by swollen spores of M. irregularis was lower in Card9−/− mice than in WT mice. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001.

The binding of β-glucan to dectin-1 might be the key factor for the different CARD9-dependent host responses to M. irregularis resting spores and swollen spores.

To figure out why Card9-dependent host responses to resting spores and swollen spores are different, we examined β-glucan on the surface of the different forms of M. irregularis spores by confocal technology. We found that β-glucan was absent in the cell walls of resting spores, while its level dramatically increased in the cell walls of swollen spores (Fig. 6a).

FIG 6.

FIG 6

The binding of β-glucan to dectin-1 might be the key factor for the different CARD9-dependent host response to M. irregularis resting spores and swollen spores. (a) Confocal images of β-glucan staining on the surface of resting spores and swollen spores. β-Glucan was absent in the cell walls of resting spores, while dramatically increased in the cell walls of swollen spores. (b) The binding of dectin-1 soluble proteins to swollen spores was much greater than to resting spores.

β-Glucan is mainly recognized by dectin-1; therefore, we tested the binding ability of different forms of M. irregularis with soluble dectin-1 proteins. The binding of dectin-1 soluble proteins to swollen spores was much greater than binding to resting spores (Fig. 6b).

From the results mentioned above, we speculate that the binding of β-glucan to dectin-1 might be the key factor for the different CARD9-dependent host responses to M. irregularis resting spores and swollen spores.

Card9 deficiency partially impairs neutrophil-dependent antifungal immunity.

Because the expression of the neutrophil-targeting chemokines CXCL1 and CXCL2 was significantly lower in Card9−/− mice than WT mice, we investigated the responses of neutrophils in combating M. irregularis infections.

We used flow cytometry to determine the ability of neutrophils from WT mice or Card9−/− mice to phagocytose fluorescein isothiocyanate (FITC)-labeled M. irregularis spores, and no significant difference was found between the mice (data not shown). Second, we detected the production of reactive oxygen species (ROS), and there was no difference (data not shown). Third, we assessed the release of neutrophil extracellular traps (NETs) following neutrophil stimulation with M. irregularis hyphae. We demonstrated that neutrophils from Card9−/− mice released dramatically fewer NETs than WT mice (Fig. 7a). Finally, we cocultured neutrophils with inactivated swollen spores of M. irregularis overnight and examined the expression of IL-6 and TNF-α in neutrophils. We found significantly lower expression in the neutrophils from Card9−/− mice than WT mice (Fig. 7b). Our results indicated that Card9 deficiency partially impairs neutrophil-dependent antifungal immunity.

FIG 7.

FIG 7

Card9 deficiency partially impairs neutrophil-dependent antifungal immunity. (a) Neutrophils from Card9−/− mice released dramatically fewer NETs than those from WT mice. (b) The expression of IL-6 and TNF-α was significantly lower in Card9−/− neutrophils than in WT neutrophils. *, P < 0.05; ***, P < 0.001.

DISCUSSION

The present study used WT and Card9−/− mice and established a murine model of subcutaneous M. irregularis infection to mimic the route of human cutaneous mucormycosis. We isolated immune cells, including BMDCs, naive T cells, BMDMs, and neutrophils, to investigate the antifungal effects of Card9 on M. irregularis in vivo and in vitro. Our results demonstrated that Card9−/− mice had higher susceptibility to M. irregularis infection than WT mice, which may be associated with impaired local cytokine and chemokine production, impaired NF-κB pathway activation, and impaired Th cell and neutrophil responses in Card9−/− mice.

The skin lesions and histopathological findings of the footpads of Card9−/− mice were consistent with M. irregularis-infected patients with CARD9 deficiency (8). Based on the similar phenotypes between the mouse model and human patients, we hypothesized that a close connection existed between CARD9 deficiency and increased susceptibility to M. irregularis infection.

Autosomal-recessive CARD9 deficiency is a primary immunodeficiency, and it leads to life-threatening, invasive fungal infections in otherwise healthy people (21). The spectrum of fungal susceptibility and clinical presentation varies based on CARD9 deficiency and fungal identity (23). Neutrophils are the most numerous white blood cells and the first-line defensive effector cells that are rapidly recruited into infectious sites after infection occurs (24). Published data demonstrated that CARD9 deficiency was associated with an impaired accumulation of neutrophils and induction of neutrophil-recruiting CXC chemokines against black yeasts, Candida and Aspergillus (12, 16, 25). A recent study by R. A. Drummond et al. showed that CARD9 mediated the accumulation of neutrophils into the central nervous system (CNS) via IL-1β and CXCL1 (26). Significantly decreased expression of neutrophil-targeting chemokines CXCL1 and CXCL2 was found in Card9−/− mice in our study, which highlighted the role of Card9 in recruiting neutrophils into infection sites to mediates immunity against M. irregularis. Our results are consistent with previous studies.

Based on the reduced numbers of neutrophils recruited to the infection sites, we wondered whether there were deficiencies in the functions of neutrophils against M. irregularis. Neutrophils are one of the most essential immune cells in innate immunity and use killing mechanisms, including phagocytosis, to eliminate pathogens, and they kill the pathogens in phagosomes using NADPH oxygenase-dependent mechanisms (ROS) or antibacterial proteins (cathepsins, defensins, lactoferrin, and lysozyme) (27). P. Liang et al. indicated that Card9−/− polymorphonuclear leukocytes (PMNs) had defects in Phialophora verrucosa killing and proinflammatory cytokine production but normal ROS generation and phagocytotic ability (28). The abilities of Card9−/− neutrophils in ROS generation and phagocytotic ability toward M. irregularis were normal in our study, which indicates the unnecessary role of Card9 in ROS generation and phagocytotic ability of neutrophils, as published previously (29, 30; data not shown). Neutrophils selectively release NETs in response to pathogens that are too large to be phagocytosed (31). NETs are extracellular weblike structures comprised of DNA and neutrophil antimicrobial proteins released after microbial or sterile inflammatory stimuli. J. T. Loh et al. demonstrated that Dok3 adaptor negatively regulated antifungal immunity in neutrophils via suppression of Card9 signaling (32). Card9−/− neutrophils produced fewer NETs against M. irregularis hyphae in our study and expressed decreased levels of IL-6 and TNF-α, which indicated that Card9 influenced the production of NETs and proinflammatory cytokines.

Impaired IL-17-dependent immunity was also associated with CARD9 deficiency (21). Th cells in adaptive immunity play essential roles in the clearing of pathogenic fungi: Th1 cells and Th17 cells render protective immunity against fungi, but Th2 cells increase susceptibility to fungal infections (33). Chronic fungal infections arise once Th1/Th2 cellular immunity becomes unbalanced, in which case, Th1 responses turn into Th2 immune responses (34). Previous studies demonstrated the significant roles of Th17 cells in fungal infections caused by Candida spp. and dematiaceous fungi (21), and Th1 cells played essential roles in Aspergillus fumigatus or Coccidioides posadasii infections (35, 36). Mucorales-specific T cells produced IFN-γ, IL-4, and IL-10, but less IL-17, and caused damage to fungal hyphae (37). Rhizopus arrhizus hyphae induced a strong release of IL-23 and TNF-α by human DCs, which drives Th1 and Th17 responses (38). Reduced production of the Th1 cytokine IFN-γ and the Th17 cytokine IL-17A and increased production of IL-10 and the Th2 cytokine IL-4 were found during chronic M. irregularis infection in Card9−/− mice in our study. Card9−/− BMDCs induced less secretion of proinflammatory cytokines and lower Th1/17 differentiation than WT BMDCs. Collectively, these findings demonstrated the importance of Th cells in the pathogenesis of mucormycosis caused by CARD9 deficiency.

At the signaling pathway level, Card9 lies downstream of C-type lectin receptors (CLRs), and it associates with BclX and Malt1 to activate the canonical NF-κB pathway and induce Th1 and Th17 cell responses (39). Card9-dependent NF-κB activation is essential in Candida albicans infection, Exophiala spinifera infection and Rhizopus arrhizus infection (12, 40). Our study showed a statistically significant reduction in NF-κB (p65) activation in Card9−/− BMDMs. This result, in combination with the findings from Th cells mentioned above, suggests that CARD9 mediates downstream Th1 and Th17 responses toward M. irregularis via the NF-κB signaling pathway.

A published report showed that the developmental stage of spores of Rhizopus oryzae corresponded to various macrophage activities, and swollen spores induced stronger macrophage activity than resting spores (41). The ability of M. irregularis spores to induce host immune responses was also stage specific in our study, which was likely due to differences in pathogen-associated molecular pattern (PAMP) exposure. However, this hypothesis needs further investigation.

Our study found that the increased susceptibility to M. irregularis in Card9−/− mice may be related to impaired neutrophil and Th cell responses. Therefore, interventions targeting neutrophils and Th cells may effectively improve the antifungal abilities of CARD9 deficiency patients. Researchers showed that granulocyte-macrophage colony-stimulating factor (GM-CSF) or granulocyte colony-stimulating factor (G-CSF) increased the number of PMNs in the blood circulation and decreased the morbidity of infections (42). Exogenous GM-CSF and G-CSF as adjunctive immunotherapy successfully controlled Candida CNS infections in three patients with CARD9 deficiency, but no significant effect was observed in a fourth patient with same infection (4345). Two patients with CARD9 deficiency were successfully treated with hematopoietic stem cell transplantation (HSCT) (46). Neutropenia is an important risk factor of mucormycosis, and several patients suffering from mucormycosis were successfully cured with combined applications of exogenous GM-CSF or G-CSF and antifungal therapy (47, 48). Published studies demonstrated the positive antifungal potentials of IFN-γ in several patients with candidiasis or Aspergillus terreus infection (49, 50). All of these studies support the importance of leukocytes in CARD9-related antifungal immunity.

The immune system is a complex network that is composed of multiple immune cells, cytokines, and complement. Our study performed in vivo and in vitro experiments, which provided some results on the antifungal effects of Card9 on M. irregularis. These results enriched our knowledge of the relationship between CARD9 deficiency and mucormycosis, but they may not fully reflect the host immune response against Mucorales. Due to the heterogeneity between mice and humans, our results require further verification in humans. More attention must be paid to the links between primary immunodeficiency, especially CARD9 deficiency, and M. irregularis infection in clinical practice, and deeper fundamental studies elucidating the host immune responses against M. irregularis are urgently needed to exploit novel immunotherapeutic strategies.

MATERIALS AND METHODS

Mice.

Card9-deficient (Card9−/−) mice on the C57BL/6 background were generous gifts from Xin Lin (Tsinghua University School of Medicine, Beijing, China). The C57BL/6 WT mice (Vital River Laboratory, Beijing, China) and Card9−/− mice used in this study were male (6 to 10 weeks old) and maintained under specific-pathogen-free conditions. Animal experiments were performed following protocols approved by the Ethics Committee of Peking University First Hospital.

Fungus.

A clinical isolate of M. irregularis (BMU09468) kept in the Research Center for Medical Mycology at Peking University was used in this study. This isolate was from the first Card9-deficient patient with cutaneous mucormycosis caused by M. irregularis.

The isolate was grown on potato dextrose agar (PDA) for 4 to 6 days at 28°C to obtain abundant resting spores. A fungal suspension was prepared at 2.5 × 109 CFU/ml. Resting spores were inactivated with 4% paraformaldehyde. Swollen spores were prepared via the shaking of resting spores in RPMI 1640 medium at 37°C for 5 h at a speed of 200 rpm/min and subsequently inactivated according to the protocol used for resting spores.

In vivo infection with M. irregularis.

The fungal suspension (100 μl) was subcutaneously injected into the hind footpads of WT and Card9−/− mice. Normal saline was used as a negative control. All animals were monitored daily to assess survival rates. Mice were sacrificed at 3 and 7 dpi for cytokine profiling, at 3 dpi for chemokine profiling, at 3, 7, and 28 dpi for fungal burden analysis, and at 28 dpi for histopathological examination.

In vivo analysis—histopathological examination, fungal burden analysis, cytokine profiling.

For histopathological examination, formalin‐fixed footpads from WT and Card9−/− mice were processed and embedded in paraffin. Sections (5 μm) were stained with hematoxylin and eosin (H&E) and periodic acid‐Schiff (PAS) stain.

For fungal burden analysis, footpads were weighed up and homogenized manually in 1 ml normal saline by using sterile glass homogenizers, then the homogenates were collected, 10‐fold dilutions were performed, and then 100-μl samples of each of the diluted homogenates were added into PDA culture dishes. CFU were counted after incubation on PDA supplemented with chloramphenicol at 28°C for 12 h. Values were marked as log10 spore equivalents per gram of tissue.

For cytokine profiling, Cytometric Bead Array (CBA) kits (Becton Dickinson) were used to measure the levels of inflammatory cytokines in the supernatant of footpad homogenates from WT and Card9−/− mice according to the manufacturer's instructions. Data were analyzed by FCAP Array software according to the “Guide to Analyzing Data from BD CBA Kits Using FCAP Array Software” at bdbiosciences.com/cbasetup (https://www.bdbiosciences.com/en-us/applications/research-applications/bead-based-immunoassays).

Chemokine profiles.

RNA was extracted from 3-dpi footpad homogenates using the E.Z.N.A Total RNA kit (Omega Bio-tek, Norcross, GA, USA), and cDNA was reverse transcribed using Prime-Script RT master mix (TaKaRa, Shiga, Japan). The gene expression of cxcl1, cxcl2, Il6, tnfa, T-bet, and ROR-γt was quantified by quantitative PCR (qPCR). The primers used are listed in Table 1.

TABLE 1.

Primers used for qPCR amplification

Gene Sequence of:
Forward primers Reverse primers
Tnfa 5′-GCCTCTTCTCATTCCTGCTTG-3′ 5′‐CTGATGAGAGGGAGGCCATT‐3′
Il6 5′‐ACGGCCTTCCCTACTTCACA‐3′ 5′‐CATTTCCACGATTTCCCAGA‐3′
Cxcl1 5′‐GGCGCCTATCGCCAATG‐3′ 5′‐CTGGATGTTCTTGAGGTGAATCC‐3′
Cxcl2 5′‐AAGTTTGCCTTGACCCTGAA‐3′ 5′‐AGGCACATCAGGTACGATCC‐3′
T-bet 5′‐GCCAGGGAACCGCTTATATG‐3′ 5′‐GGACGATCATCTGGGTCACAT‐3′
ROR-γt 5′‐TCTACACGGCCCTGGTTCTC‐3′ 5′‐GCCTTGTCGATGAGTCTTGCA‐3′
gapdh 5′‐TCGTCCCGTAGACAAAATGGT‐3′ 5′‐TCTCCACTTTGCCACTGCAA‐3′

NF-κB (p65) transcription factor assay.

BMDMs and their nuclear extracts were obtained as previously described (40). An NF-κB (p65) transcription factor assay kit (Cayman Chemical, USA) was used to detect specific NF-κB (p65) DNA-binding activity in the nuclear extracts following the manufacturer’s instructions.

Cell culture medium and reagents.

The medium for cell culture was RPMI 1640 complete medium (Gibco, Invitrogen, San Diego, CA, USA) containing 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 g/ml streptomycin. Mouse recombinant GM-CSF and IL-4 were obtained from PeproTech (Rocky Hill, NJ, USA). LPS, curdlan, trypan blue and β-1,3-d-glucanase were purchased from Sigma-Aldrich (St. Louis, MO, USA). Ionomycin was obtained from Enzo (Farmingdale, NY, USA). β-(1-3)-Glucan-specific monoclonal antibody and goat anti-mouse secondary antibody were from BioSupplies (Australia) and Life Technologies (USA). Dectin-1 soluble protein and anti-mouse dectin antibody were purchased from R&D Systems (USA).

β-(1-3)-Glucan staining in the fungal cell wall.

Inactivated resting spores and swollen spores were stained with β-(1-3)-glucan antibody (1 μg/ml) for 1 h, washed twice with PBS containing 1% goat serum and then stained with Alexa Fluor 488 goat anti-mouse secondary antibody for another 30 min, and washed twice with phosphate-buffered saline (PBS). Images were acquired in a Leisa TCS SP5 fluorescence confocal microscope (Leica, Micro-systems, GmbH).

Dectin-1 binding assay.

Inactivated resting spores and swollen spores were incubated with dectin-1 soluble protein (10 μg/ml) for 1 h, washed twice with PBS, and stained with phycoerythrin (PE) anti-mouse dectin-1 antibody for 30 min, and washed twice with PBS, and fluorescence was detected with a BD FACSCalibur flow cytometer.

Measurement of cytokine secretion by DCs.

Bone marrow cells were isolated by flushing the femur and tibia of mice with RPMI 1640 medium under aseptic conditions and cultured in RPMI 1640 complete medium containing GM-CSF and IL-4. The cells were harvested and purified using CD11c+ microbeads (Miltenyi Biotec, Auburn, CA, USA) on the seventh day. Ninety-six-well plates were seeded with DCs (2 × 105 cells/well), and resting spores or swollen spores were cocultured with the DCs at a multiplicity of infection (MOI) of 2 or 1, respectively. The mock group was the negative control, and curdlan (100 μg/ml) and LPS (10 μg/ml) were prepared as positive controls. The supernatants were collected after 24 h, and the levels of the cytokines IL-1β, IL-12p70, and IL-23 were detected using mouse enzyme linked immunosorbent assay (ELISA) Ready-Set-GO! kits (eBioscience, San Diego, CA, USA).

Measurement of Th1/17 cell differentiation.

DCs and spores were added to 48-well plates as described above and cultured for 24 h. Naïve mouse CD4+ T cells were sorted using a naive CD4+ T cell isolation kit (Miltenyi Biotec, Auburn, CA, USA). The T cells were added into the coculture system containing immature DCs and spores (at a ratio of DCs to T cells of 1:10). Four days later, the cells were restimulated with phorbol myristate acetate (PMA; 50 ng/ml), ionomycin (500 ng/ml), and GolgiStop (10 μg/ml) for 5 h. The cells were stained with FITC-conjugated anti-mouse CD3, PE- and Cy5-conjugated anti-mouse CD4, PE-conjugated anti-mouse IL-17A, allophycocyanin-conjugated anti-mouse IFN-γ and isotype control antibodies (BD Pharmingen, USA). The percentage of Th1/Th17 cells was analyzed using flow cytometry. Supernatants from the DC and T cell coculture system were collected before restimulation, and the levels of IFN-γ and IL-17A were measured using a mouse IFN-γ ELISA kit and mouse IL-17A ELISA kit (Dakewei, Shenzhen, China), respectively.

Preparation of neutrophils, the NETosis assay, and qPCR.

Mature neutrophils were prepared as described previously (51). A 24-well plate was seeded with purified neutrophils (5 × 104 cells/well) before stimulation with inactivated hyphae (MOI of 10). Propidium iodide (PI) was added 4 h later, and the cells were analyzed for NET release using microscopy. A 24-well plate was also seeded with purified neutrophils (1 × 106 cells/well) before stimulation with inactivated swollen spores at an MOI of 2 overnight. RNA was extracted from the neutrophils, cDNA was reversed transcribed, and the gene expression of Il6 and tnfa was quantified by qPCR as described above.

Statistical analysis.

All the results are shown as the means ± standard errors of the means (SEM) and were calculated using GraphPad Prism (version 6.0). A two-tailed Student's t test was used to compare differences (significant at P < 0.05) between two groups, and one-way analysis of variance (ANOVA) was used to compare three or more groups. P values are represented as follows: ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001; and ****, P < 0.0001.

ACKNOWLEDGMENTS

This study was supported by grants no. 81520108026 and no. 81371783 from the National Natural Science Foundation of China.

We gratefully thank Xin Lin for generously providing the Card9 knockout mice.

We declare that we have no conflicts of interest and that the research was performed in the absence of any commercial or financial relationships that may be construed as a potential conflict of interest.

Jin Yu and Ruoyu Li designed the experiments. Lingyue Sun and Shuzhen Zhang performed the experiments. Lingyue Sun, Shuzhen Zhang, Ruoyu Li, and Jin Yu analyzed the experimental results. Zhe Wan contributed reagents, materials, and analysis tools, and Lingyue Sun wrote the manuscript. All authors read and approved the final manuscript.

REFERENCES

  • 1.Pilmis B, Alanio A, Lortholary O, Lanternier F. 2018. Recent advances in the understanding and management of mucormycosis. F1000Res 7:1429. 10.12688/f1000research.15081.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. 2012. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54:S23–S34. 10.1093/cid/cir866. [DOI] [PubMed] [Google Scholar]
  • 3.Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, Chen SC. 2019. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect 25:26–34. 10.1016/j.cmi.2018.07.011. [DOI] [PubMed] [Google Scholar]
  • 4.Spellberg B, Edwards J, Jr, Ibrahim A. 2005. Novel perspectives on mucormycosis: pathophysiology. presentation, and management. Clin Microbiol Rev 18:556–569. 10.1128/CMR.18.3.556-569.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wei LW, Wang H, Song YG, Yu J. 2019. Disfiguring Mucor irregularis infection cured by amphotericin B and itraconazole: a case report and treatment experience. Mycopathologia 184:677–682. 10.1007/s11046-019-00380-5. [DOI] [PubMed] [Google Scholar]
  • 6.Chander J, Kaur M, Bhalla M, Punia RS, Singla N, Bhola K, Alastruey-Izquierdo A, Stchigel AM, Guarro J. 2015. Changing epidemiology of mucoralean fungi: chronic cutaneous infection caused by Mucor irregularis. Mycopathologia 180:181–186. 10.1007/s11046-015-9908-z. [DOI] [PubMed] [Google Scholar]
  • 7.Rammaert B, Angebault C, Scemla A, Fraitag S, Lerolle N, Lecuit M, Bougnoux ME, Lortholary O. 2014. Mucor irregularis-associated cutaneous mucor-mycosis: case report and review. Med Mycol Case Rep 6:62–65. 10.1016/j.mmcr.2014.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wang X, Wang A, Wang X, Li R, Yu J. 2019. Cutaneous mucormycosis caused by Mucor irregularis in a patient with CARD9 deficiency. Br J Dermatol 180:213–214. 10.1111/bjd.17144. [DOI] [PubMed] [Google Scholar]
  • 9.Wang X, Ding H, Chen Z, Zeng X, Sun J, Chen H, Fu M. 2020. CARD9 deficiency in a Chinese man with cutaneous mucormycosis, recurrent deep dermatophytosis and a review of the literature. Mycopathologia 185:1041–1050. 10.1007/s11046-020-00487-0. [DOI] [PubMed] [Google Scholar]
  • 10.Drummond RA, Franco LM, Lionakis MS. 2018. Human CARD9: a critical molecule of fungal immune surveillance. Front Immunol 9:1836. 10.3389/fimmu.2018.01836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Huang C, Zhang Y, Song Y, Wan Z, Wang X, Li R. 2019. Phaeohyphomycosis caused by Phialophora americana with CARD9 mutation and 20-year literature review in China. Mycoses 62:908–919. 10.1111/myc.12962. [DOI] [PubMed] [Google Scholar]
  • 12.Wang X, Zhang R, Wu W, Song Y, Wan Z, Han W, Li R. 2018. Impaired specific anti-fungal immunity in CARD9-deficient patients with phaeohyphomycosis. J Invest Dermatol 138:607–617. 10.1016/j.jid.2017.10.009. [DOI] [PubMed] [Google Scholar]
  • 13.Wang X, Wang W, Lin Z, Wang X, Li T, Yu J, Liu W, Tong Z, Xu Y, Zhang J, Guan L, Dai L, Yang Y, Han W, Li R. 2014. CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies. J Allergy Clin Immunol 133:905–908.e3. 10.1016/j.jaci.2013.09.033. [DOI] [PubMed] [Google Scholar]
  • 14.Gavino C, Mellinghoff S, Cornely OA, Landekic M, Le C, Langelier M, Golizeh M, Proske S, Vinh DC. 2018. Novel biallelic splice mutations in CARD9 causing adult-onset Candida endophthalmitis. Mycoses 61:61–65. 10.1111/myc.12701. [DOI] [PubMed] [Google Scholar]
  • 15.Herbst M, Gazendam R, Reimnitz D, Sawalle-Belohradsky J, Groll A, Schlegel PG, Belohradsky B, Renner E, Klepper J, Grimbacher B, Kuijpers T, Liese J. 2015. Chronic Candida albicans meningitis in a 4-year-old girl with a homozygous mutation in the CARD9 gene (Q295X). Pediatr Infect Dis J 34:999–1002. 10.1097/INF.0000000000000736. [DOI] [PubMed] [Google Scholar]
  • 16.Rosentul DC, Delsing CE, Jaeger M, Plantinga TS, Oosting M, Costantini I, Venselaar H, Joosten LA, van der Meer JW, Dupont B, Kullberg BJ, Sobel JD, Netea MG. 2014. Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis. Front Microbiol 5:483. 10.3389/fmicb.2014.00483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rieber N, Gazendam RP, Freeman AF, Hsu AP, Collar AL, Sugui JA, Drummond RA, Rongkavilit C, Hoffman K, Henderson C, Clark L, Mezger M, Swamydas M, Engeholm M, Schüle R, Neumayer B, Ebel F, Mikelis CM, Pittaluga S, Prasad VK, Singh A, Milner JD, Williams KW, Lim JK, Kwon-Chung KJ, Holland SM, Hartl D, Kuijpers TW, Lionakis MS. 2016. Extrapulmonary Aspergillus infection in patients with CARD9 deficiency. JCI Insight 1:e89890. 10.1172/jci.insight.89890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhang Y, Mijiti J, Huang C, Song Y, Wan Z, Li R, Kang X, Wang X. 2019. Deep dermatophytosis caused by Microsporum ferrugineum in a patient with CARD9 mutations. Br J Dermatol 181:1093–1095. 10.1111/bjd.18146. [DOI] [PubMed] [Google Scholar]
  • 19.Nazarian RM, Lilly E, Gavino C, Hamilos DL, Felsenstein D, Vinh DC, Googe PB. 2020. Novel CARD9 mutation in a patient with chronic invasive dermatophyte infection (tinea profunda). J Cutan Pathol 47:166–170. 10.1111/cup.13574. [DOI] [PubMed] [Google Scholar]
  • 20.Lanternier F, Pathan S, Vincent QB, Liu L, Cypowyj S, Prando C, Migaud M, Taibi L, Ammar-Khodja A, Stambouli OB, Guellil B, Jacobs F, Goffard J-C, Schepers K, Del Marmol V, Boussofara L, Denguezli M, Larif M, Bachelez H, Michel L, Lefranc G, Hay R, Jouvion G, Chretien F, Fraitag S, Bougnoux M-E, Boudia M, Abel L, Lortholary O, Casanova J-L, Picard C, Grimbacher B, Puel A. 2013. Deep dermatophytosis and inherited CARD9 deficiency. N Engl J Med 369:1704–1714. 10.1056/NEJMoa1208487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Corvilain E, Casanova JL, Puel A. 2018. Inherited CARD9 deficiency: invasive disease caused by ascomycete fungi in previously healthy children and adults. J Clin Immunol 38:656–693. 10.1007/s10875-018-0539-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wurster S, Thielen V, Weis P, Walther P, Elias J, Waaga-Gasser AM, Dragan M, Dandekar T, Einsele H, Löffler J, Ullmann AJ. 2017. Mucorales spores induce a proinflammatory cytokine response in human mononuclear phagocytes and harbor no rodlet hydrophobins. Virulence 8:1708–1718. 10.1080/21505594.2017.1342920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pilmis B, Puel A, Lortholary O, Lanternier F. 2016. New clinical phenotypes of fungal infections in special hosts. Clin Microbiol Infect 22:681–687. 10.1016/j.cmi.2016.05.016. [DOI] [PubMed] [Google Scholar]
  • 24.Kobayashi SD, DeLeo FR. 2009. Towards a comprehensive understanding of the role of neutrophils in innate immunity: a systems biology-level approach. Wiley Interdiscip Rev Syst Biol Med 1:309–333. 10.1002/wsbm.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Drummond RA, Collar AL, Swamydas M, Rodriguez CA, Lim JK, Mendez LM, Fink DL, Hsu AP, Zhai B, Karauzum H, Mikelis CM, Rose SR, Ferre EM, Yockey L, Lemberg K, Kuehn HS, Rosenzweig SD, Lin X, Chittiboina P, Datta SK, Belhorn TH, Weimer ET, Hernandez ML, Hohl TM, Kuhns DB, Lionakis MS. 2015. CARD9-dependent neutrophil recruitment protects against fungal invasion of the central nervous system. PLoS Pathog 11:e1005293. 10.1371/journal.ppat.1005293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Drummond RA, Swamydas M, Oikonomou V, Zhai B, Dambuza IM, Schaefer BC, Bohrer AC, Mayer-Barber KD, Lira SA, Iwakura Y, Filler SG, Brown GD, Hube B, Naglik JR, Hohl TM, Lionakis MS. 2019. CARD9+ microglia promote antifungal immunity via IL-1β- and CXCL1-mediated neutrophil recruitment. Nat Immunol 20:559–570. 10.1038/s41590-019-0377-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kolaczkowska E, Kubes P. 2013. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13:159–175. 10.1038/nri3399. [DOI] [PubMed] [Google Scholar]
  • 28.Liang P, Wang X, Wang R, Wan Z, Han W, Li R. 2015. CARD9 deficiencies linked to impaired neutrophil functions against Phialophora verrucosa. Mycopathologia 179:347–357. 10.1007/s11046-015-9877-2. [DOI] [PubMed] [Google Scholar]
  • 29.Németh T, Futosi K, Sitaru C, Ruland J, Mócsai A. 2016. Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced inflammation in vivo. Nat Commun 7:11004. 10.1038/ncomms11004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Drewniak A, Gazendam RP, Tool AT, van Houdt M, Jansen MH, van Hamme JL, van Leeuwen EM, Roos D, Scalais E, de Beaufort C, Janssen H, van den Berg TK, Kuijpers TW. 2013. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 121:2385–2392. 10.1182/blood-2012-08-450551. [DOI] [PubMed] [Google Scholar]
  • 31.Branzk N, Lubojemska A, Hardison SE, Wang Q, Gutierrez MG, Brown GD, Papayannopoulos V. 2014. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat Immunol 15:1017–1025. 10.1038/ni.2987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Loh JT, Xu S, Huo JX, Kim SS, Wang Y, Lam KP. 2019. Dok3-protein phosphatase 1 interaction attenuates Card9 signaling and neutrophil-dependent antifungal immunity. J Clin Invest 129:2717–2729. 10.1172/JCI126341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.LeibundGut-Landmann S, Wuthrich M, Hohl TM. 2012. Immunity to fungi. Curr Opin Immunol 24:449–458. 10.1016/j.coi.2012.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Romani L, Kaufmann SH. 1998. Immunity to fungi: editorial overview. Res Immunol 149:277–281. 10.1016/s0923-2494(98)80751-7. [DOI] [PubMed] [Google Scholar]
  • 35.Hung CY, Castro-Lopez N, Cole GT. 2016. Card9- and MyD88-mediated gamma interferon and nitric oxide production is essential for resistance to subcutaneous Coccidioides posadasii infection. Infect Immun 84:1166–1175. 10.1128/IAI.01066-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Chai LY, van de Veerdonk F, Marijnissen RJ, Cheng SC, Khoo AL, Hectors M, Lagrou K, Vonk AG, Maertens J, Joosten LA, Kullberg BJ, Netea MG. 2010. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology 130:46–54. 10.1111/j.1365-2567.2009.03211.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Potenza L, Vallerini D, Barozzi P, Riva G, Forghieri F, Zanetti E, Quadrelli C, Candoni A, Maertens J, Rossi G, Morselli M, Codeluppi M, Paolini A, Maccaferri M, Del Giovane C, D’Amico R, Rumpianesi F, Pecorari M, Cavalleri F, Marasca R, Narni F, Luppi M. 2011. Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic in high risk patients. Blood 118:5416–5419. 10.1182/blood-2011-07-366526. [DOI] [PubMed] [Google Scholar]
  • 38.Chamilos G, Ganguly D, Lande R, Gregorio J, Meller S, Goldman WE, Gilliet M, Kontoyiannis DP. 2010. Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of TH-17 responses. PLoS One 5:e12955. 10.1371/journal.pone.0012955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Roth S, Bergmann H, Jaeger M, Yeroslaviz A, Neumann K, Koenig PA, Prazeres da Costa C, Vanes L, Kumar V, Johnson M, Menacho-Márquez M, Habermann B, Tybulewicz VL, Netea M, Bustelo XR, Ruland J. 2016. Vav proteins are key regulators of Card9 signaling for innate antifungal immunity. Cell Rep 17:2572–2583. 10.1016/j.celrep.2016.11.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sun L, Wan Z, Li R, Yu J. 2019. Impairment of Th cell response in Card9 knockout mice with cutaneous mucormycosis caused by Rhizopus arrhizus. Exp Dermatol 28:1244–1251. 10.1111/exd.14020. [DOI] [PubMed] [Google Scholar]
  • 41.Levitz SM, Selsted ME, Ganz T, Lehrer RI, Diamond RD. 1986. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis 154:483–489. 10.1093/infdis/154.3.483. [DOI] [PubMed] [Google Scholar]
  • 42.Antachopoulos C, Roilides E. 2005. Cytokines and fungal infections. Br J Haematol 129:583–596. 10.1111/j.1365-2141.2005.05498.x. [DOI] [PubMed] [Google Scholar]
  • 43.Celmeli F, Oztoprak N, Turkkahraman D, Seyman D, Mutlu E, Frede N, Köksoy S, Grimbacher B. 2016. Successful granulocyte colony-stimulating factor treatment of relapsing Candida albicans meningoencephalitis caused by CARD9 deficiency. Pediatr Infect Dis J 35:428–431. 10.1097/INF.0000000000001028. [DOI] [PubMed] [Google Scholar]
  • 44.Gavino C, Cotter A, Lichtenstein D, Lejtenyi D, Fortin C, Legault C, Alirezaie N, Majewski J, Sheppard DC, Behr MA, Foulkes WD, Vinh DC. 2014. CARD9 deficiency and spontaneous central nervous system candidiasis: complete clinical remission with GM-CSF therapy. Clin Infect Dis 59:81–84. 10.1093/cid/ciu215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Gavino C, Hamel N, Zeng B, Legault C, Guiot M, Chankowsky J, Lejtenyi D, Lemire M, Alarie I, Dufresne S, Boursiquot JN, McIntosh F, Langelier M, Behr MA, Sheppard DC, Foulkes WD, Vinh DC. 2016. Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians. J Allergy Clin Immunol 137:1178–1188. 10.1016/j.jaci.2015.09.016. [DOI] [PubMed] [Google Scholar]
  • 46.Queiroz-Telles F, Mercier T, Maertens J, Sola CBS, Bonfim C, Lortholary O, Constantino-Silva RMN, Schrijvers R, Hagen F, Meis JF, Herkert PF, Breda GL, França JB, Filho NAR, Lanternier F, Casanova JL, Puel A, Grumach AS. 2019. Successful allogenic stem cell transplantation in patients with inherited CARD9 deficiency. J Clin Immunol 39:462–469. 10.1007/s10875-019-00662-z. [DOI] [PubMed] [Google Scholar]
  • 47.Mastroianni A. 2004. Paranasal sinus mucormycosis in an immunocompetent host: efficacy and safety of combination therapy with liposomal amphotericin B and adjuvant rHuGM-CSF. Infez Med 12:278–283. [PubMed] [Google Scholar]
  • 48.Ma B, Seymour JF, Januszewicz H, Slavin MA. 2001. Cure of pulmonary Rhizomucor pusillus infection in a patient with hairy-cell leukemia: role of liposomal amphotericin B and GM-CSF. Leuk Lymphoma 42:1393–1399. 10.3109/10428190109097768. [DOI] [PubMed] [Google Scholar]
  • 49.Buddingh EP, Leentjens J, van der Lugt J, Dik WA, Gresnigt MS, Netea MG, Pickkers P, Driessen GJ. 2015. Interferon-gamma immunotherapy in a patient with refractory disseminated candidiasis. Pediatr Infect Dis J 34:1391–1394. 10.1097/INF.0000000000000909. [DOI] [PubMed] [Google Scholar]
  • 50.Assendorp EL, Gresnigt MS, Sprenkeler EGG, Meis JF, Dors N, van der Linden JWM, Henriet SSV. 2018. Adjunctive interferon-γ immunotherapy in a pediatric case of Aspergillus terreus infection. Eur J Clin Microbiol Infect Dis 37:1915–1922. 10.1007/s10096-018-3325-4. [DOI] [PubMed] [Google Scholar]
  • 51.Xue J, Zhao Z, Zhang L, Xue L, Shen S, Wen Y, Wei Z, Wang L, Kong L, Sun H, Ping Q, Mo R, Zhang C. 2017. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat Nanotechnol 12:692–700. 10.1038/nnano.2017.54. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES